Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins
Abstract Purpose The objective of this study is to determine primary survival endpoints in women with recurrent and metastatic endometrial carcinoma (RMEC) treated with progestins. Methods A retrospective chart review was conducted at The Ottawa Hospital using electronic medical records. Inclusion c...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2023-08-01
|
| Col·lecció: | Cancer Medicine |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/cam4.6276 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|